Abugassa S, Nordenström J, Eriksson S, Sjödén G
Department of Surgery, Huddinge University Hospital, Sweden.
J Clin Endocrinol Metab. 1993 Jun;76(6):1617-21. doi: 10.1210/jcem.76.6.8501170.
Photon absorptiometry was used to measure skeletal mass in the proximal femur, lumbar spine, and distal radius in 19 females with hypoparathyroidism after operation for either thyroid carcinoma or hyperparathyroidism. Healthy subjects as well as normocalcemic patients who had undergone the same surgical procedure without developing hypoparathyroidism were used as controls. Skeletal mass was measured after a mean postoperative time of 13 and 10 yr in patients operated on for thyroid carcinoma and hyperparathyroidism, respectively. Bone mass was 10-32% greater in hypoparathyroid patients than in controls. In patients with retained parathyroid function after total thyroidectomy and surgical treatment of hyperparathyroidism, bone mass did not differ from that in age-matched healthy controls. Long term T4 medication in doses that suppressed endogenous TSH production was not associated with a decreased bone mass. Reduced PTH production, vitamin D treatment, and calcium supplementation may all have contributed to the increased bone mass found in the patients with postsurgical hypoparathyroidism.
采用光子吸收法对19例因甲状腺癌或甲状旁腺功能亢进手术后发生甲状旁腺功能减退的女性患者的股骨近端、腰椎和桡骨远端的骨量进行了测量。健康受试者以及接受相同手术但未发生甲状旁腺功能减退的血钙正常患者作为对照。分别对因甲状腺癌和甲状旁腺功能亢进接受手术的患者在术后平均13年和10年时测量骨量。甲状旁腺功能减退患者的骨量比对照组高10% - 32%。在全甲状腺切除术后保留甲状旁腺功能并接受甲状旁腺功能亢进手术治疗的患者中,骨量与年龄匹配的健康对照组无差异。长期服用抑制内源性促甲状腺激素分泌剂量的甲状腺素与骨量减少无关。甲状旁腺激素分泌减少、维生素D治疗和补钙可能都促成了手术后甲状旁腺功能减退患者骨量增加。